This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA approves tamoxifen to reduce breast cancer risk
U S health officials approve tamoxifen for women at high risk of breast cancer, a move with potential to affect millions. The drug lowers cancer risk but raises uterine cancer, clot, and cataract risks, requiring careful patient selection and informed consent.
MENTIONED IN THIS ARTICLE
Washington
and Drug Administration
FDA
Michael Friedman
Kathy Albain
Loyola University Medical School
Albain
National Cancer Institute
Allen Lichter
American Society For Clinical Oncology
Lichter
Zeneca Inc
Nolvadex
NCI
Harmon Eyre
American Cancer Society
Eyre